Dr. Christian P. Schultz, Ph.D., Director Molecular Imaging, Siemens Medical Solutions

Christian received his B.S., M.S. and Ph.D. degrees from the Free University of Berlin in 1982, 1986 and 1993 in Biochemistry and Biophysics. Starting in 1984, Christian began developing methods in infrared spectroscopy/imaging for biomedical applications within a joint research program of the Free University of Berlin and the Robert Koch Institute – a member of the former Federal Health Office of Germany. After creating multiple infrared methods in the field of bacteriology and active participation in government grant work concerning instrument prototyping, he then joined a Canadian Initiative in Biomedical Sciences at the Institute for Biodiagnostics in Winnipeg - a member of the National Research Council of Canada. Christian created and implemented key methods for Cancer detection and other disease diagnoses based on infrared technologies in collaboration with local hospital environments and international research groups. In 1999, he joined the Optics Branch of Bruker in the US focusing on translating research applications in Life Sciences into industrial Genomics and Proteomics products. After creating a US Life Sciences division within Bruker Optics Inc, he also directed their high-throughput screening initiative, suitable for product development in infrared-based proteomics and cell screening. Christian then transitioned from Life Science applications development to medical diagnostics by joining Global Business Development with Siemens Medical Solutions. He is currently director of Molecular Imaging acting out of the Massachusetts General Hospital focused on transitioning molecular imaging research into commercial device and applications development for future clinical and small animal imaging.